RU97115149A - METHOD FOR VACCINATION AGAINST VIRAL HEPATITIS IN - Google Patents

METHOD FOR VACCINATION AGAINST VIRAL HEPATITIS IN

Info

Publication number
RU97115149A
RU97115149A RU97115149/14A RU97115149A RU97115149A RU 97115149 A RU97115149 A RU 97115149A RU 97115149/14 A RU97115149/14 A RU 97115149/14A RU 97115149 A RU97115149 A RU 97115149A RU 97115149 A RU97115149 A RU 97115149A
Authority
RU
Russia
Prior art keywords
vaccination against
against viral
viral hepatitis
administration
months
Prior art date
Application number
RU97115149/14A
Other languages
Russian (ru)
Other versions
RU2116086C1 (en
Inventor
В.Г. Акимкин
С.В. Скворцов
Л.М. Самоходская
Б.Н. Лыцарь
В.Н. Борисова
М.В. Буданов
И.М. Яковлева
Original Assignee
Акционерное общество закрытого типа НПК "Комбиотех Лтд"
Главный военный клинический госпиталь им.акад.Н.Н.Бурденко
Filing date
Publication date
Application filed by Акционерное общество закрытого типа НПК "Комбиотех Лтд", Главный военный клинический госпиталь им.акад.Н.Н.Бурденко filed Critical Акционерное общество закрытого типа НПК "Комбиотех Лтд"
Priority to RU97115149A priority Critical patent/RU2116086C1/en
Priority claimed from RU97115149A external-priority patent/RU2116086C1/en
Application granted granted Critical
Publication of RU2116086C1 publication Critical patent/RU2116086C1/en
Publication of RU97115149A publication Critical patent/RU97115149A/en

Links

Claims (3)

1. Способ вакцинации против вирусного гепатита В, включающий последовательные внутримышечные введения вакцины, содержащей антиген вируса гепатита В, полученный путем культивирования трансформированных клеток штамма S. cerevisiae ВКПМ-У-2203, отличающийся тем, что введение вакцины проводят двухкратно, при этом второе введение осуществляют через 2-5 месяцев после первого.1. The method of vaccination against viral hepatitis B, comprising sequential intramuscular administration of a vaccine containing hepatitis B virus antigen obtained by culturing transformed cells of the strain S. cerevisiae VKPM-U-2203, characterized in that the vaccine is administered twice, while the second administration is carried out 2-5 months after the first. 2. Способ вакцинации против вирусного гепатита В, отличающийся тем, что второе введение преимущественно проводят через 4-5 месяцев после первого. 2. A method of vaccination against viral hepatitis B, characterized in that the second administration is preferably carried out 4-5 months after the first. 3. Способ вакцинации против вирусного гепатита В, отличающийся тем, что второе введение по экстренным показаниям проводят через 2-3 месяца после первого. 3. The method of vaccination against viral hepatitis B, characterized in that the second administration according to emergency indications is carried out 2-3 months after the first.
RU97115149A 1997-08-19 1997-08-19 Method of vaccination against viral hepatitis b RU2116086C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU97115149A RU2116086C1 (en) 1997-08-19 1997-08-19 Method of vaccination against viral hepatitis b

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU97115149A RU2116086C1 (en) 1997-08-19 1997-08-19 Method of vaccination against viral hepatitis b

Publications (2)

Publication Number Publication Date
RU2116086C1 RU2116086C1 (en) 1998-07-27
RU97115149A true RU97115149A (en) 1999-01-27

Family

ID=20197040

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97115149A RU2116086C1 (en) 1997-08-19 1997-08-19 Method of vaccination against viral hepatitis b

Country Status (1)

Country Link
RU (1) RU2116086C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2130779C1 (en) * 1998-07-31 1999-05-27 Акционерное общество закрытого типа Научно-производственная компания "Комбиотех Лтд" Mixed vaccine for immune prophylaxis of viral hepatitis b, tetanus and diphtheria

Similar Documents

Publication Publication Date Title
CA2102918A1 (en) Genetic vaccine for immunodeficiency viruses
EP0755259A4 (en) CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON
GR3026569T3 (en) Oral vaccine comprising antigen surface-associated with red blood cells
EP0232798A3 (en) Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
WO1993001210A3 (en) Hcv peptide-antigens and a method of testing for the hepatitis c virus (hcv)
EP0342860A3 (en) Novel protein, sequences containing the gene therefore, vectors, methods of preparation and use
US7094408B2 (en) Immunogenicity using a combination of DNA and vaccinia virus vector vaccines
NL189207C (en) FLAVIVIRUS ANTIGEN, PROCESS FOR THE PREPARATION THEREOF, INTERMEDIATES AND PROCESS FOR PREPARING A VACCINE AGAINST JAPANESE ENCEPHALITIS.
JP2002534481A5 (en)
WO2001016163A3 (en) Peptide mixture and vaccine against a chronic viral infection
Flehmig et al. Simultaneous vaccination for hepatitis A and B
DE3585578D1 (en) HEPATITIS SURFACE ANTI-PARTICLE VACCINE.
KR920002629A (en) Amino Acid Residue Sequence of Hepatitis B Core Antigen
KR950005326A (en) Recombinant Adenovirus Vaccine
RU97115149A (en) METHOD FOR VACCINATION AGAINST VIRAL HEPATITIS IN
EP0400569A3 (en) Method for preparing a vaccine from Streptococcus mutans for dental caries and vaccinal compositions for dental caries used as nasal drops
EP0023731A3 (en) Process for the preparation of polyvalent virus vaccines in a single cell system, such polyvalent vaccines and their application
MY128929A (en) Vaccine against hepatitis a and hepatitis b
Gerin et al. Recombinant DNA and synthetic peptide approaches to HBV vaccine development: Immunogenicity and protective efficacy in chimpanzees.
BIBERFELD et al. Prevention of HIV-2 and SIVSM infection in cynomolgus monkeys by active or passive immunization
Zourbas et al. Immunization of dental surgeons against hepatitis B virus infection.
EP0320034A3 (en) New immunologically active synthetic peptides useful for preparing an antimalarial vaccine
ATE84722T1 (en) RABIES LIVE VACCINE.
EP0309898A3 (en) Method for the induction of a cytotoxic t cell response
EP0293201A3 (en) Method of vaccination for hepatitis b virus